Brian Lian insider trades

Open-market stock purchases and sales by Brian Lian, President & CEO at Viking Therapeutics, Inc, from SEC Form 4 filings since May 4, 2015.

Recent trades

DateStockTradeValue
Jul 29, 2026VKTX Viking Therapeutics, IncSold$4.9M
Jul 28, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Jan 5, 2026VKTX Viking Therapeutics, IncSold$4.3M
Jan 5, 2026VKTX Viking Therapeutics, IncSold$1.8M
Jan 5, 2026VKTX Viking Therapeutics, IncSold$1.4M
Jan 5, 2026VKTX Viking Therapeutics, IncSold$224K
Jan 2, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Jan 2, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Jan 2, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Oct 28, 2025VKTX Viking Therapeutics, IncSold$1.4M
Oct 27, 2025VKTX Viking Therapeutics, IncBought (not open market)—

Companies traded

  • VKTX Viking Therapeutics, Inc: 35 sales, last Jul 29, 2026
  • SEEL Seelos Therapeutics, Inc: other filings, last Jan 4, 2024

Get free alerts when Brian Lian files a new trade →